Teva Doubles Down On Alvotech Biosimilars Partnership

Invests $40m, Adds Two More Biosimilars To Deal And Actively Supports Quality Efforts

 
• By David Wallace
  
Cogs with Quality and Manufacturing words
Teva will get more actively involved in Alvotech’s quality processes • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business